A phase 2 study of the safety, tolerability, and pharmacodynamics of FBS0701, a novel oral iron chelator, in transfusional iron overload
Supplemental materials for Neufeld et al
Files in this Data Supplement:
Document 1. Supplemental Figures and Tables (PDF, 1 MB)